More than $21 million goes to combat opioid crisis in Wisconsin, from latest round of opioid settlement funding
The money is part of $75 million in funds the state has received since 2022 from legal settlements with opioid makers, ...
I help patients kick opioid habits. More potent naloxone not the answer. | Opinion
Wisconsin should not use opioid settlement dollars on treatments that don't work such as the higher-dose formulations of the ...
Medpage Today on MSN1d
Study Questions Genetic Test for Opioid Addiction Risk
A new study questioned the clinical utility of an algorithm meant to predict opioid use disorder (OUD) risk based on 15 ...
Opioid overdose deaths dropped in two biggest N.H. cities, though positive trend ‘could quickly change’
The mayors of Manchester and Nashua celebrated the good news, as preliminary data suggest opioid overdose deaths declined in ...
Science behind genetic testing for identifying risk of opioid misuse remains unproven, says study
Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, ...
healthday on MSN8d
Phone App May Help Treat Opioid Use Disorder, Data Suggests
A smartphone app appears to help people battle opioid use disorder (OUD).People with OUD had 35% fewer days of opioid ...
Many in need of substance use disorder treatment are not receiving it
A gap persists between the need for and receipt of substance use disorder (SUD) treatment among U.S. individuals, according ...
healthday on MSN1d
Many in Need of Substance Use Disorder Treatment Not Receiving It
A gap persists between the need for and receipt of substance use disorder (SUD) treatment among U.S. individuals, ac ...
clinicalpainadvisor.com1d
Augmenting Medications With Phone App Boosts Opioid Addiction Recovery Success
Augmenting MOUD with smartphone app-based contingency management is beneficial for uninsured or underinsured adults.
Opioid Use Disorder Treatment Market Size In The 7MM Was ~USD 5.6 Billion In 2023, Projected To Grow By 2034
Companies like Pfizer, Amgen, AbbVie, Novartis, and others are advancing Opioid Use Disorder treatments, focusing on improving symptoms and patient ...
psychiatryadvisor.com3d
Few Receive Meds for Opioid Use Disorder After Nonfatal Overdose
In the 12 months after a nonfatal overdose, few Medicare beneficiaries receive medications for opioid use disorder (MOUD) or fill a naloxone prescription.